abrdn Life Sciences Investors (CIK 884121) is an SEC-registered fund company and $560.8M in net assets as of 2026-03-31.
| Series | Net assets |
|---|---|
| abrdn Life Sciences Investors | $560.8M |
| Holding | Value |
|---|---|
| Insmed Inc | $17.0M |
| Vaxcyte Inc | $16.7M |
| uniQure NV | $15.9M |
| Argenx SE | $14.3M |
| Dyne Therapeutics Inc | $13.9M |
| Denali Therapeutics Inc | $12.8M |
| Axsome Therapeutics Inc | $12.5M |
| Xenon Pharmaceuticals Inc | $11.8M |
| Fulcrum Therapeutics Inc | $11.6M |
| Tectonic Therapeutic Inc | $11.5M |
| NEUROVANCE MILESTONE INTEREST | $11.5M |
| Crinetics Pharmaceuticals Inc | $11.3M |
| Edgewise Therapeutics Inc | $11.1M |
| Immunovant Inc | $11.0M |
| Alnylam Pharmaceuticals Inc | $10.0M |